Supply problems following the entry of pregabalin caps into category M in August – and subsequent concession pricing – have conflated to see seven lines of the drug join the risers for August.
The price of pregabalin caps 50mg x84 rose by an average 694 per cent in August as the drug tariff price fell and a concession price of £19.95 was granted. Most companies increased prices. By the end of the month the difference between the highest and lowest prices was over £94, leaving little chance for any buyer to find low-priced stock without making a phone call. The companies making the most offers to the market – presumably because of a larger stock holding – were Alliance and Numark.
DDA members can view the full detail of the August purchase price analysis by visiting the library of analyses in DDA Online’s dispensary management zone.